甲状腺髓样癌的发病率、诊疗组织与外科治疗趋势:一项基于人群的研究
该研究基于荷兰癌症登记处与病理登记库,纳入1989至2018年共795例组织学确诊的甲状腺髓样癌患者,分析30年间发病率、诊疗机构、淋巴结清扫及生存趋势。结果显示人群标化发病率保持稳定,为每年每10万人0.17±0.04例(p=0.247),诊疗向学术医院集中,中央颈淋巴结清扫比例升高,总生存改善。
要点
- 30年间甲状腺髓样癌人群标化发病率稳定,为每年每10万人0.17±0.04例(p=0.247)。
- 在学术医院接受治疗的患者比例从A阶段的41%升至B阶段的58%和C阶段的86%(两者p<0.001)。
- 中央颈淋巴结清扫在C阶段(93%)比A阶段(77%)或B阶段(87%)更常实施(p=0.009,p=0.027)。
核心结论
- 研究显示过去三十年荷兰甲状腺髓样癌人群发病率稳定,生存改善,治疗向学术医院集中且中央颈淋巴结清扫率升高,可能分别与集中化和推荐指南的引入有关。
研究设计与样本
- 研究为基于人群的队列研究,从荷兰癌症登记处识别1989至2018年所有组织学确诊的甲状腺髓样癌患者,并链接荷兰病理登记库(PALGA)。
- 共纳入795例患者,比较A阶段(1989-1998年)、B阶段(1999-2008年)和C阶段(2009-2018年)的临床病理参数、淋巴结手术范围及结局。
主要发现
- 30年间人群标化发病率保持稳定,为每年每10万人0.17±0.04例(p=0.247)。
- 795例患者中54%为女性,63%在学术医院治疗,中位年龄48岁(四分位距[IQR] 34-61)。
- 诊断时年龄从A阶段的42岁(IQR 25-61)增至C阶段的52岁(IQR 42-63)(p<0.001)。
- 学术医院治疗比例从A阶段的41%升至B阶段的58%和C阶段的86%(两者p<0.001)。
- 582例(73%)患者在初次治疗时接受淋巴结清扫,其中88%行中央颈淋巴结清扫(CND),36%行单侧颈淋巴结清扫,20%行双侧颈淋巴结清扫。
关键数值与推荐
- CND在C阶段(93%)比A阶段(77%)或B阶段(87%)更常实施(p=0.009,p=0.027)。
- 总生存从A阶段(55%)改善至C阶段(88%)(p=0.022),从B阶段(65%)改善至C阶段(p=0.007)。
- 局部区域复发率保持稳定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Medullary thyroid cancer (MTC) is a rare cancer with variable disease course. To enable optimal care, centralization and consensus guidelines are essential. This study describes trends in the incidence, organization of care, surgical treatment, and outcomes of MTC over 30 years in the Netherlands. Methods: All patients with a histological MTC diagnosis between 1989 and 2018 were identified from the Netherlands Cancer Registry and linked to the Dutch Pathology register (PALGA). Incidence rates, relative to the Dutch population, were assessed throughout time. Clinicopathological parameters and extent of lymph node (LN) surgery were extracted from PALGA pathology reports. Period A (1989-1998), period B (1999-2008), and period C (2009-2018) were compared. Results: Throughout 30 years, the population-adjusted incidence remained stable with 0.17 ± 0.04 diagnoses per 100,000 people per year (p = 0.247). Of all 795 patients, 54% were female and 63% were treated in an academic hospital, at a median age of 48 years (interquartile range [IQR] 34-61). Age at diagnosis increased over time from 42 years (IQR 25-61) in period A to 52 years (IQR 42-63) in period C (p < 0.001). The proportion of treatments occurring in an academic hospital increased from 41% of patients in period A to 58% and 86% in period B and C, respectively (both p < 0.001). At primary treatment, a LN dissection was performed in 582 (73%) patients. Of these patients, 88%, 36%, and 20% underwent a central neck dissection (CND), unilateral neck dissection, and bilateral neck dissection, respectively. CND was performed more frequently in period C (93%) than in period A (77%) or B (87%) (p = 0.009, p = 0.027, respectively). Overall survival improved from period A (55%) to C (88%) and B (65%) to C (p = 0.022, p = 0.007, respectively). Locoregional recurrence rates remained stable. Conclusions: This study shows a stable incidence and improved survival of MTC in the Dutch population over the last three decades. In addition, these data indicate a transition of treatment to academic hospitals, likely due to centralization, and a higher rate of CNDs, following the introduction of recommendation guidelines.
引用
- Jager EC, Metman MJH, Timmenga IAC, et al. Trends in the Incidence, Organization of Care, and Surgical Treatment of Medullary Thyroid Cancer: A Population-Based Study. Thyroid. 2024. PMID: 39705074. doi:10.1089/thy.2024.0433
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。